These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
256 related articles for article (PubMed ID: 23342977)
1. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney. Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of hydrogen sulfide on gentamicin-induced renal injury. Otunctemur A; Ozbek E; Dursun M; Sahin S; Besiroglu H; Ozsoy OD; Cekmen M; Somay A; Ozbay N Ren Fail; 2014 Jul; 36(6):925-31. PubMed ID: 24679071 [TBL] [Abstract][Full Text] [Related]
3. Pomegranate extract attenuates gentamicin-induced nephrotoxicity in rats by reducing oxidative stress. Cekmen M; Otunctemur A; Ozbek E; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N Ren Fail; 2013; 35(2):268-74. PubMed ID: 23176634 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects montelukast, cysteinyl-leukotriene receptor antagonist, on renal damage after unilateral ureteral obstruction in rats. Otunctemur A; Ozbek E; Cakir SS; Dursun M; Cekmen M; Polat EC; Ozcan L; Somay A; Ozbay N Int Braz J Urol; 2015; 41(2):279-87. PubMed ID: 26005969 [TBL] [Abstract][Full Text] [Related]
5. Protective effect of nebivolol on gentamicin-induced nephrotoxicity in rats. Dursun M; Sahin S; Besiroglu H; Otunctemur A; Ozbek E; Cakir SS; Cekmen M; Somay A Bratisl Lek Listy; 2018; 119(11):718-725. PubMed ID: 30686006 [TBL] [Abstract][Full Text] [Related]
6. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist. Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892 [TBL] [Abstract][Full Text] [Related]
7. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production. Helmy MM; El-Gowelli HM Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of ebselen, a selenoorganic drug, against gentamicin-induced renal damage in rats. Dhanarajan R; Abraham P; Isaac B Basic Clin Pharmacol Toxicol; 2006 Sep; 99(3):267-72. PubMed ID: 16930301 [TBL] [Abstract][Full Text] [Related]
17. Renoprotective effects of montelukast, a cysteinyl leukotriene receptor antagonist, against methotrexate-induced kidney damage in rats. Abdel-Raheem IT; Khedr NF Naunyn Schmiedebergs Arch Pharmacol; 2014 Apr; 387(4):341-53. PubMed ID: 24363042 [TBL] [Abstract][Full Text] [Related]
18. Gastroprotective effect of leukotriene receptor blocker montelukast in alendronat-induced lesions of the rat gastric mucosa. Sener G; Kapucu C; Cetinel S; Cikler E; Ayanoğlu-Dülger G Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):1-11. PubMed ID: 15589394 [TBL] [Abstract][Full Text] [Related]